Medivation Inc (MDVN) financial statements (2020 and earlier)

Company profile

Business Address 525 MARKET STREET
SAN FRANCISCO, CA 94105
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments226503229296
Cash and cash equivalents22650322971
Short-term investments   225
Restricted cash and investments10  
Prepaid expense and other current assets12
Deferred tax assets 22  
Other undisclosed current assets40719712536
Total current assets:634722354344
Noncurrent Assets
Property, plant and equipment58411713
Intangible assets, net (including goodwill)663111
Goodwill1910  
Intangible assets, net (excluding goodwill)644101  
Restricted cash and investments1212109
Other noncurrent assets71112
Prepaid expense and other noncurrent assets6
Deferred tax assets, net5715  
Total noncurrent assets:7971903928
TOTAL ASSETS:1,432912393372
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1207018564
Accounts payable231032
Accrued liabilities35227949
Employee-related liabilities29332413
Taxes payable332  
Interest and dividends payable02  
Accounts payable and other accrued liabilities79 
Business combination, contingent consideration, liability510
Deferred revenue and credits 31734
Other undisclosed current liabilities14137(106)(13)
Total current liabilities:2661209685
Noncurrent Liabilities
Long-term debt and lease obligation 222208196
Long-term debt, excluding current maturities 222208196
Liabilities, other than long-term debt2751021721
Deferred revenue and credits   8
Deferred tax liabilities, net 064
Other liabilities136129
Business combination, contingent consideration, liability26296
Other undisclosed noncurrent liabilities1719(6)(4)
Total noncurrent liabilities:293343220213
Total liabilities:559462316298
Stockholders' equity
Stockholders' equity attributable to parent8734497774
Common stock2111
Additional paid in capital685506410364
Accumulated other comprehensive income   0
Retained earnings (accumulated deficit)186(58)(334)(292)
Total stockholders' equity:8734497774
TOTAL LIABILITIES AND EQUITY:1,432912393372

Income statement (P&L) ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating expenses(529)(429)(295)(208)
Other undisclosed operating income943710273182
Operating income (loss):415282(22)(26)
Nonoperating expense(33)(22)(20)(15)
Interest and debt expense(21)(23)(20) 
Income (loss) from continuing operations before equity method investments, income taxes:360237(63)(41)
Other undisclosed income from continuing operations before income taxes212320 
Income (loss) from continuing operations before income taxes:381260(42)(41)
Income tax expense (benefit)(137)16(0)(0)
Net income (loss) available to common stockholders, basic:245276(43)(41)
Interest on convertible debt414  
Net income (loss) available to common stockholders, diluted:248290(43)(41)

Comprehensive Income ($ in millions)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):245276(43)(41)
Other comprehensive income (loss)  (0)0
Comprehensive income (loss), net of tax, attributable to parent:245276(43)(41)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: